Form D · Biotechnology
Beyond Air, Inc.
Garden City, NY · CIK 0001641631
Offering snapshot reported Oct 11, 2024 · SEC filing
- Reported sold
- $20.6M Offering amount: $20.6M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 11, 2024 | Initial | $20,600,000 | No comparison | 15 | SEC filing |
| Jul 9, 2024 | Initial | $128,000 | No comparison | 2 | SEC filing |
| Jun 28, 2023 | Initial | $1,375,000 | No comparison | 2 | SEC filing |
| Jun 18, 2019 | Initial | $7,960,635 | No comparison | 47 | SEC filing |
| Mar 1, 2018 | Initial | $9,810,155 | No comparison | 58 | SEC filing |
| Apr 12, 2017 | Initial | $663,000 | No comparison | 22 | SEC filing |
| Jan 31, 2017 | Initial | $36,978,258 | No comparison | 58 | SEC filing |
| May 8, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.44M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-526618
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BTIG, LLC | 122225 | |
| Brookline Capital Markets, a division of Arcadia Securities, LLC | 44656 | |
| Laidlaw & Company (UK) LTD | 119037 | |
| JONESTRADING INSTITUTIONAL SERVICES LLC | 6888 |
Source: Form D, filed Oct 11, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Avniel Amir | Director, Executive |
| Yossef Av Gay | Director |
| Haim Aviv | Executive |
| Hai Aviv | Executive |
| Amir Avniel | Director, Executive |
| Ron Bentsur | Director |
| Robert Carey | Director |
| Beck Douglas | Executive |
| Lucera Erick | Director |
| William P. Forbes | Director |
| Michael A. Gaul | Executive |
| David Grossman | Director |
| Jason Lane | Director, Executive |
| Douglas Quinton Larson | Executive |
| Yoori Lee | Director |
| Steven A. Lisi | Director, Executive |
| Erick Lucera | Director |
| Jeff Lynn Myers | Executive |
| Ari Raved | Director |
| Carey Robert | Director |
| Bentsur Ron | Director |
| Racheli Vizman | Executive |
| Forbes William | Director |
| Lee Yoori | Director |
| Jerome Zeldis | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
900 Stewart Avenue Suite 301
Garden City, NY, 11530
Garden City, NY, 11530